Back To TOP

LUCENTIS Co-pay Card

The LUCENTIS Co-pay Card Program can help reduce the out-of-pocket costs for the medication LUCENTIS. If you have commercial or private insurance and meet other eligibility requirements, this program can help regardless of your income level.

 

 

Qualified Patients

To qualify for this program, you must:

  • Be treated with LUCENTIS for
    • Neovascular (Wet) Age-related Macular Degeneration (AMD)
    • Macular Edema following Retinal Vein Occlusion (RVO)
    • Diabetic Macular Edema (DME)
  • Do you have “commercial” or “private” insurance?
    • You must not be covered by a government-funded health care program. These include Medicare, Medicare Advantage, Medicare Replacement, Medicaid, TRICARE, and government employee plans
  • Have insurance to cover LUCENTIS, but are required to pay a co-pay or co-insurance
  • Live in the United States or Puerto Rico, but do not live in or receive treatment in Vermont (where the program is not available)
  • Not be receiving help from the Genentech® Access to Care Foundation, or GATCF, or other co-pay foundations for LUCENTIS

 

 

What the card covers

The LUCENTIS Co-Pay Card can cover some of the out-of-pocket costs for LUCENTIS. This may also be called “co-pay,” “co-insurance” or “uncovered expense.”

 

 

To enroll in the LUCENTIS Co-Pay Card, call (855) 218-5307 from 9 AM to 8 PM ET, Monday through Friday, or go to www.LucentisCoPayCard.com.

FAQs

 
Q:

Can LUCENTIS Access Solutions help me with an appeal if my claim is denied?

 
A: 

Yes, we work with you and your doctor's office.
We do this if your prior authorization is turned down.

 

 

Q:

 

I have no health care plan or my plan won’t pay for LUCENTIS. My doctor wants me to be on LUCENTIS. What can I do?

 
A: 

You might be able to get help from the Genentech® Access to Care Foundation. It can assist eligible people who need help paying for LUCENTIS.

 
View All

Learn More About
Lucentis
  • LEARN about treatment with LUCENTIS
  • LEARN HOW the LUCENTIS Co-pay Card can help with the out-of-pocket costs for LUCENTIS
  • Form Patient Authorization and Notice of Release of Information (Current Version)

Who is LUCENTIS for?

LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), and diabetic macular edema (DME).

What important safety information should I know about LUCENTIS?

LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious eye infections. You should not use LUCENTIS if you have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients. Some LUCENTIS patients have had increased eye pressure within 1 hour of an injection. Serious side effects also include inflammation inside the eye and, rarely, problems related to the injection procedure, such as cataracts. Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes. If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor immediately. Ask your doctor if you have questions or want more information.

You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.

For additional safety information, please talk to your doctor and see the LUCENTIS full Prescribing Information.